Analyst consensus rating
Tenax Therapeutics Analyst Rating: Buy
Direct answer
Tenax Therapeutics's consensus rating is Buy.
9 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $12.56.
Forecast evidence checked October 17, 2026.
Get free Tenax Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.36
- Average price target
- $12.56
- High price target
- $36.00
- Low price target
- $4.00
- Low target gap
- +194.1%
- Target upside
- +823.2%
- High target gap
- +2,547.1%
- Target range width
- 2,352.9%
- Consensus rating
- Buy
- Analysts
- 9
- Evidence date
- October 17, 2026
- Valid through
- October 24, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Tenax Therapeutics?
Tenax Therapeutics has a verified Buy consensus. The same dataset has an average price target of $12.56.
How far are Tenax Therapeutics's low and high targets from the recorded price?
The low target implies +194.1%, while the high target implies +2,547.1%.
How many analysts are included in Tenax Therapeutics's consensus?
The verified consensus includes 9 analysts.
How is Tenax Therapeutics's target upside or downside calculated?
The average target of $12.56 is divided by the recorded price of $1.36, then one is subtracted to produce +823.2%. This does not guarantee a future return.
When was Tenax Therapeutics's analyst forecast verified?
The data was verified on 2026-10-17. The dataset is valid through 2026-10-24.